SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : UTHR-a Promising Biotech in the works here?
UTHR 445.43-1.8%Oct 31 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LzzrdKing who wrote (23)8/25/1999 6:29:00 AM
From: kendall harmon   of 66
 
UTHR Phase II results--A simple way to consider the potential impact of the Barcelona paper next week is to look at the action in BCRX yesterday. BCRX had positive phase II results on their product which will treat flu:

cbs.marketwatch.com.

UTHR will be presenting its phase II results for its product which treats pulmonary hypertension. Now we could have a debate about which is a potential bigger market, etc., but the point is that phase II results are potentially important events for biotechnology stocks.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News